Title: Incidence of Sero-prevalence of Hepatitis virus Among HIV Positive Individuals in Tertiary Care Hospital at, North Bihar, India

Authors: Dr Sanjay Kumar, Dr S. N. Singh, Dr Satyendu Sagar

 DOI: https://dx.doi.org/10.18535/jmscr/v7i5.46

Abstract

Objective: The Co-infection of Hepatitis B and C viruses with HIV accelerate disease progression and also have an effect on the management of patients infected with HIV. There was a broad distribution of incidence and prevalence of HIV Co-infection with hepatitis viruses. This study is planned to evaluate the prevalence of HIV Co-infection with Hepatitis B and C viruses in North Bihar.

Materials and Methods: A total of 720 patients enrolled in the ART centre were retrospectively analyzed for the presence of HBV and HCV on the basis of the presence of HBsAg and anti-HCV markers.

Results: In patients infected with HIV, the prevalence of Co-infection with HBV was 9.44% (68/720), the prevalence of Co-infection with HCV was 2.91% (21/720) and the prevalence of Co-infection with both HBV and HCV was 0.7% (approximate 1%, 5/720).

Conclusion: The prevalence rate of HBV and HCV are increasing in patients infected with HIV and that’s why the knowledge about the importance of such a Co-infection, it is mandatory to all the HIV positive patients should be screened for HBV and HCV Co-infection for the longevity of the patients.

Keywords:  HIV, HBV, HCV, sero-prevalence, Co-infection.

References

  1. Sulkowski MS. Viral hepatitis and HIV Co-infection. J Hepatol 2008;48:353-67.
  2. Rustgi VK, Hoofnagle JH, Gerin JL, Gelmann EP, Reichert CM, Cooper JN, et al. Hepatitis B virus infection in the acquired immunodeficiency syndrome. Ann Intern Med 1984; 101:795-7.
  3. Chung RT. Hepatitis C and B viruses: the new opportunists in HIV infection. Top HIV Med 2006; 14:78-83.
  4. Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, et al. Increasing mortality due to end stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001; 32:492-7.
  5. Thio CL, Scaberg EC, Skolasky R Jr, Phair J, Visscher B, Munoz A, et al. HIV-1, hepatitis B virus and risk of liver related mortality in the Multicenter cohort study (MACS). Lancet 2002; 360:1921-6.
  6. Rouet F, Chaix ML, Inwoley A, Anaky MF, Fassionou P, Kpozehouen A, et al. Frequent occurrence of chronic hepatities B virus infection among West African HIV type I infected children. Clin Infect Dis 2008; 46:361-6.
  7. Tankhiwale SS, Khadase RK, Jalgoanker SV. Seroprevalence of anti HCV and hepatitis B surface antigen in HIV infected patients. Indian J Med Microbiol 2003;21:268-70.
  8. Kumarasamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH. Natural history of human immuno-deficiency virus disease in southern India. Clin Infect Dis 2003:36:79-85.
  9. National AIDS Control Organization (NACO). HIV/AIDS epidemiological Surveillance and Estimation report for the year 2005. Available from http://www.nacoonline.org/. [Last accessed on 2007 Jun 10].
  10. Alter Mj. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006:44:56-9.

Corresponding Author

Dr Satyendu Sagar

Assistant Professor, Department of Microbiology, Nalanda Medical College, Patna, India